Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 70518-4590

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 70518-4590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (37fc8b27 Bf23 4fe6 8d44 5331bde5b466 01)

FDA Label Image

Image (3cb2c28c Eb1b 4e9c Bce3 Ba8e52283221 771 1)

FDA Label Image

Image (3cb2c28c Eb1b 4e9c Bce3 Ba8e52283221 802 1)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is the description based on the text: This is a medication information for Sertraline HCI tablet manufactured by Lupin Pharma. The usual dosage instructions are provided in the insert. It is advised to keep this medication out of reach of children and store it at a temperature range of 20-25°C (68-77°F). Each bottle contains 30 tablets with excursions permitted to 15-30°C (59-86°F). The expiration date and lot number are not provided in the text. The medication is repackaged by RemedyRepack Inc., located in Indiana, PA. For more information, contact 724.465.8762.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.